Scholarly Index
Kyriakos P. Papadopoulos
South Texas Accelerated Research Therapeutics; 17,143 total citations; 483 total publications; best world rank #72
South Texas Accelerated Research Therapeutics
17,143Total citations
483Total publications
62H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Immunotherapy and Biomarkers | Lifetime | 546 | US 278 | 98.78 |
| Cancer Research and Treatments | Lifetime | 435 | US 260 | 97.64 |
| Colorectal Cancer Treatments and Studies | Lifetime | 839 | US 324 | 97.64 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 409 | US 237 | 96.84 |
| Protein Degradation and Inhibitors | Lifetime | 529 | US 264 | 96.24 |
| Advanced Breast Cancer Therapies | Lifetime | 432 | US 199 | 96.55 |
| HER2/EGFR in Cancer Research | Lifetime | 953 | US 418 | 96.25 |
| Multiple Myeloma Research and Treatments | Lifetime | 863 | US 386 | 95.99 |
| Cancer Research and Treatments | 2021-2025 | 72 | US 18 | 95.22 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 724 | US 268 | 97.24 |
| Lung Cancer Treatments and Mutations | 2021-2025 | 780 | US 241 | 95.20 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 629 | US 184 | 92.65 |
| HER2/EGFR in Cancer Research | 2021-2025 | 438 | US 166 | 92.77 |
| Cancer Treatment and Pharmacology | 2021-2025 | 718 | US 247 | 87.35 |
| Advanced Breast Cancer Therapies | 2021-2025 | 929 | US 318 | 83.96 |